These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 12072871)

  • 1. The effect of the Val34Leu polymorphism in the factor XIII gene in infants with a birth weight below 1500 g.
    Göpel W; Kattner E; Seidenberg J; Kohlmann T; Segerer H; Möller J;
    J Pediatr; 2002 Jun; 140(6):688-92. PubMed ID: 12072871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms of hemostasis genes and primary outcome of very low birth weight infants.
    Härtel C; König I; Köster S; Kattner E; Kuhls E; Küster H; Möller J; Müller D; Kribs A; Segerer H; Wieg C; Herting E; Göpel W
    Pediatrics; 2006 Aug; 118(2):683-9. PubMed ID: 16882823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Val34Leu genetic variation in the A subunit of coagulation factor XIII in recurrent spontaneous abortion.
    Bagheri M; Rad IA; Omrani MD; Nanbaksh F
    Syst Biol Reprod Med; 2011 Oct; 57(5):261-4. PubMed ID: 21548851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.
    Marín F; González-Conejero R; Lee KW; Corral J; Roldán V; López F; Sogorb F; Caturla J; Lip GY; Vicente V
    J Am Coll Cardiol; 2005 Jan; 45(1):25-9. PubMed ID: 15629368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.
    Gemmati D; Serino ML; Ongaro A; Tognazzo S; Moratelli S; Resca R; Moretti M; Scapoli GL
    Am J Hematol; 2001 Jul; 67(3):183-8. PubMed ID: 11391716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of factor XIII Val34Leu polymorphism in patients affected by spontaneous subconjunctival hemorrhage.
    Parmeggiani F; Costagliola C; Incorvaia C; Gemmati D; D'Angelo S; Tognazzo S; Scapoli GL; Sebastiani A
    Am J Ophthalmol; 2004 Sep; 138(3):481-4. PubMed ID: 15364237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gaussian distribution of intelligence in VLBW preterm infants at age 5: very low correlation with very low birth weight].
    van Baalen A; Ross C; Kewitz G; Mildenberger E; Berns M; Bartsch M; Kössel H; Kruppa E; Bohn R; Versmold H
    Z Geburtshilfe Neonatol; 2008 Apr; 212(2):57-63. PubMed ID: 18432558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-10 -1082 G/A polymorphism and risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants.
    Yanamandra K; Boggs P; Loggins J; Baier RJ
    Pediatr Pulmonol; 2005 May; 39(5):426-32. PubMed ID: 15678510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The homozygous leu variant of the factor XIII Val34Leu polymorphism as a risk factor for the manifestation of thrombotic microangiopathies.
    Sucker C; Farokhzad F; Kurschat C; Grabensee B; Scharf RE; Zotz RB; Maruhn-Debowski B; Hetzel GR
    Clin Appl Thromb Hemost; 2009; 15(2):197-200. PubMed ID: 17895511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis.
    Shafey M; Anderson JL; Scarvelis D; Doucette SP; Gagnon F; Wells PS
    Thromb Haemost; 2007 Apr; 97(4):635-41. PubMed ID: 17393027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population based study on the outcome of small for gestational age newborns.
    Bartels DB; Kreienbrock L; Dammann O; Wenzlaff P; Poets CF
    Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F53-9. PubMed ID: 15613577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of haemostasis genes as risk factors for preterm delivery.
    Härtel C; von Otte S; Koch J; Ahrens P; Kattner E; Segerer H; Möller J; Diedrich K; Göpel W
    Thromb Haemost; 2005 Jul; 94(1):88-92. PubMed ID: 16113789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor XIII Val34Leu polymorphism is associated with increased factor XIII activation and decreased transcutaneous oxygen readings in patients with diabetic foot ulcers.
    Küper MA; Schüle R; Mayer P; Königsrainer A; Beckert S
    Diabet Med; 2012 Dec; 29(12):1596-9. PubMed ID: 22578139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe intraventricular hemorrhage in preterm infants: comparison of risk factors and short-term neonatal morbidities between grade 3 and grade 4 intraventricular hemorrhage.
    Sarkar S; Bhagat I; Dechert R; Schumacher RE; Donn SM
    Am J Perinatol; 2009 Jun; 26(6):419-24. PubMed ID: 19267317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FXIII gene Val34Leu polymorphism in Turkish children with cerebral infarct.
    Akar N; Dönmez B; Deda G
    J Child Neurol; 2007 Feb; 22(2):222-4. PubMed ID: 17621488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early neutropenia is not associated with an increased rate of nosocomial infection in very low-birth-weight infants.
    Teng RJ; Wu TJ; Garrison RD; Sharma R; Hudak ML
    J Perinatol; 2009 Mar; 29(3):219-24. PubMed ID: 19078971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of genes involved in the innate immune system as predictors of sepsis in very low birth weight infants.
    Ahrens P; Kattner E; Köhler B; Härtel C; Seidenberg J; Segerer H; Möller J; Göpel W;
    Pediatr Res; 2004 Apr; 55(4):652-6. PubMed ID: 14739370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis.
    Van Hylckama Vlieg A; Komanasin N; Ariëns RA; Poort SR; Grant PJ; Bertina RM; Rosendaal FR
    Br J Haematol; 2002 Oct; 119(1):169-75. PubMed ID: 12358922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years.
    Rallidis LS; Politou M; Komporozos C; Panagiotakos DB; Belessi CI; Travlou A; Lekakis J; Kremastinos DT
    Thromb Haemost; 2008 Jun; 99(6):1085-9. PubMed ID: 18521512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
    de la Red G; Tàssies D; Espinosa G; Monteagudo J; Bové A; Plaza J; Cervera R; Reverter JC
    Thromb Haemost; 2009 Feb; 101(2):312-6. PubMed ID: 19190815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.